Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 29, 2013
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab
A Matucci, S Pratesi, G Petroni, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1993
New joint imaging tools in osteoarthritis. I--Validation and preliminary experience with GGGS treatment
U Serni, G Marin, A Matucci, et al.
Allergy
|
May 3, 2018
IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolution
A Vultaggio, F Nencini, A Carraresi, et al.
Scandinavian Journal of Immunology
|
December 28, 2017
Immunoglobulin replacement therapy for yellow nail syndrome
C Lo Conte, C Allegrini, A Matucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 8, 1999
Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions
F Brugnolo, F Annunziato, S Sampognaro, et al.
Clinics and Research in Hepatology and Gastroenterology
|
September 28, 2013
Autoimmune hepatitis in a patient affected by neuromyelitis optica: a new association
R G Romanelli, F Fassio, F Cappelli, et al.
Poultry Science
|
February 11, 2015
Cloning, expression, and antigenic characterization of recombinant protein of Mycoplasma gallisepticum expressed in Escherichia coli
T S Rocha, C Tramuta, S Catania, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 22, 2021
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA
S Bormioli, A Vultaggio, F Nencini, et al.
The Journal of Rheumatology. Supplement
|
February 1, 1995
Plasminogen activator and receptor in osteoarthritis
U Serni, G Fibbi, E Anichini, et al.
Clinical and Experimental Immunology
|
August 30, 2016
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions
A Vultaggio, G Petroni, S Pratesi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 29, 2013
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab
A Matucci, S Pratesi, G Petroni, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1993
New joint imaging tools in osteoarthritis. I--Validation and preliminary experience with GGGS treatment
U Serni, G Marin, A Matucci, et al.
Allergy
|
May 3, 2018
IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolution
A Vultaggio, F Nencini, A Carraresi, et al.
Scandinavian Journal of Immunology
|
December 28, 2017
Immunoglobulin replacement therapy for yellow nail syndrome
C Lo Conte, C Allegrini, A Matucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 8, 1999
Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions
F Brugnolo, F Annunziato, S Sampognaro, et al.
Clinics and Research in Hepatology and Gastroenterology
|
September 28, 2013
Autoimmune hepatitis in a patient affected by neuromyelitis optica: a new association
R G Romanelli, F Fassio, F Cappelli, et al.
Poultry Science
|
February 11, 2015
Cloning, expression, and antigenic characterization of recombinant protein of Mycoplasma gallisepticum expressed in Escherichia coli
T S Rocha, C Tramuta, S Catania, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 22, 2021
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA
S Bormioli, A Vultaggio, F Nencini, et al.
The Journal of Rheumatology. Supplement
|
February 1, 1995
Plasminogen activator and receptor in osteoarthritis
U Serni, G Fibbi, E Anichini, et al.
Clinical and Experimental Immunology
|
August 30, 2016
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions
A Vultaggio, G Petroni, S Pratesi, et al.
Page
of 4